Abstract
CD99 is a heavily O-glycosylated 32-kD type I transmembrane protein that is expressed on most hematopoietic cells. We show here that CD99 is expressed on endothelial cells and is concentrated at the borders between confluent cells. We found that a monoclonal antibody to CD99, hec2, selectively inhibited diapedesis of monocytes across endothelial cells by >90%. Diapedesis involved the homophilic interaction of CD99 on monocytes with CD99 on endothelial junctions. CD99 functioned distally to the point at which platelet-endothelial cell adhesion molecule 1 (PECAM-1, also known as CD31), another adhesion molecule involved in transmigration, played its critical role. Confocal microscopy showed that anti–PECAM-1 arrested leukocytes on the apical surface of endothelium, whereas blocking CD99 arrested monocytes at a point where they were partially through the junction. Therefore, diapedesis, the forward migration of leukocytes through endothelial junctions, is regulated sequentially by two distinct molecules, PECAM-1 and CD99.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Butcher, E. C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67, 1033–1036 (1991).
Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76, 301–314 (1994).
Muller, W. A. in Inflammation: Basic principles and clinical correlates (eds Gallin, J. I. & Snyderman, R.) 585–592 (Lippincott Williams & Wilkins, Philadelphia, 1999).
Campbell, J. J. et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279, 381–384 (1998).
Zimmerman, G. A., McIntyre, T. M., Mehra, M. & Prescott, S. M. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling inercellular adhesion. J. Cell. Biol. 110, 529–540 (1990).
Muller, W. A., Weigl, S. A., Deng, X. & Phillips, D. M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178, 449–460 (1993).
Liao, F. et al. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182, 1337–1343 (1995).
Berman, M. E., Xie, Y. & Muller, W. A. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, PECAM-1) in natural killer cell transendothelial migration and β2 integrin activation. J. Immunol. 156, 1515–1524 (1996).
Liao, F., Ali, J., Greene, T. & Muller, W. A. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185, 1349–1357 (1997).
Bogen, S., Pak, J., Garifallou, M., Deng, X. & Muller, W. A. Monoclonal antibody to murine PECAM-1 [PECAM-1] blocks acute inflammation in vivo. J. Exp. Med. 179, 1059–1064 (1994).
Christofidou-Solomidou, M., Nakada, M. T., Williams, J., Muller, W. A. & Delisser, H. M. Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J. Immunol. 158, 4872–4878 (1997).
Gumina, R. J. et al. Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 94, 3327–3333 (1996).
Vaporciyan, A. A. et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262, 1580–1582 (1993).
Liao, F., Schenkel, A. R. & Muller, W. A. Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J. Immunol. 163, 5640–5648 (1999).
Duncan, G. S. et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): PECAM-1-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162, 3022–3030 (1999).
Bernard, A. in Leukocyte Typing VI. Proceedings of the VIth International Leukocyte Differentiation Antigen Workshop, Kobe, Japan, 1996 (ed. Kishimoto, T.) 75–77 (Garland Publishers, London, 1997).
Gelin, C. et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 8, 3253–3259 (1989).
Bernard, G. et al. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J. Immunol. 154, 26–32 (1995).
Choi, E. Y. et al. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes. J. Immunol. 161, 749–754 (1998).
Bernard, G. et al. Apoptosis of immature thymocytes mediated by E2/CD99. J. Immunol. 158, 2543–2550 (1997).
Hahn, J.-H. et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J. Immunol. 159, 2250–2258 (1997).
Waclaveicek, M. et al. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J. Immunol. 161, 4671–4678 (1998).
Wingett, D., Forcier, K. & Nielson, C. P. A role for CD99 in T cell activation. Cell. Immunol. 193, 17–23 (1999).
Bernard, G. et al. CD99 (E2) up-regulates α4β1-dependent T cell adhesion at inflamed vascular endothelium under flow conditions. Eur. J. Immunol. 30, 3061–3065 (2000).
Muller, W. A., Ratti, C. M., McDonnell, S. L. & Cohn, Z. A. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170, 399–414 (1989).
Newman, P. J. et al. PECAM-1 [PECAM-1] cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219–1222 (1990).
Ali, J., Liao, F., Martens, E. & Muller, W. A. Vascular endothelial cadherin (VE-Cadherin): Cloning and role in endothelial cell-cell adhesion. Microcirculation 4, 267–277 (1997).
Sobocka, M. B. et al. Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 95, 2600–2609 (2000).
Muller, W. A. & Weigl, S. Monocyte-selective transendothelial migration: Dissection of the binding and transmigration phases by an in vitro assay. J. Exp. Med. 176, 819–828 (1992).
Murohara, T., Delyani, J. A., Albelda, S. M. & Lefer, A. M. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol. 156, 3550–3557 (1996).
Randolph, G. J. & Furie, M. B. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J. Immunol. 155, 3610–3618 (1995).
Nose, A., Tsuji, K. & Takeichi, M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61, 147–155 (1990).
Nagafuchi, A. & Takeichi, M. Cell binding function of E-Cadherin is regulated by the cytoplasmic domain. EMBO J. 7, 3679–3684 (1988).
Jaffe, S. H. et al. Differential effects of the cytoplasmic domains of cell adhesion molecules on cell aggregation and sorting-out. Proc. Natl Acad. Sci. USA 87, 3589–3593 (1990).
Muller, W. A., Berman, M. E., Newman, P. J., Delisser, H. M. & Albelda, S. M. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule-1 [PECAM-1]. J. Exp. Med. 175, 1401–1404 (1992).
Xie, Y. & Muller, W. A. Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule-1. Proc. Natl Acad. Sci. USA 90, 5569–5573 (1993).
Delisser, H. M. et al. Platelet/endothelial cell adhesion molecule-1 (PECAM-1)-mediated cellular aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268, 16037–16046 (1993).
Sun, J. et al. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J. Biol. Chem. 271, 18561–18570 (1996).
Banting, G. S., Pym, B., Darling, S. M. & Goodfellow, P. N. The MIC2 gene product: Epitope mapping and structural prediction analysis define an integral membrane protein. Mol. Immunol. 26, 181–188 (1989).
Aubrit, F., Gelin, C., Pham, D., Raynal, B. & Bernard, A. The biochemical characterization of E2, a T cell surface molecule involved in rosettes. Eur. J. Immunol. 19, 1431–1436 (1989).
Ellis, N. A. et al. PBDX is the XG blood group gene. Nature Genet. 8, 285–290 (1994).
Ellis, N. A. et al. Cloning of PBDX, an MIC2-related gene that spans the pseudoautosomal boundary on chromosome Xp. Nature Genet. 6, 394–400 (1994).
Alberti, I. et al. PKCα mediates modulation of T cell adhesion events under CD99 engagement. FASEB J. 15, A332. (2001)
Smith, C. W. et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J. Clin. Invest. 87, 609–618 (1991).
Kitayama, J., Hidemura, A., Saito, H. & Nagawa, H. Shear stress affects migration behavior of polymorphonuclear cells arrested on endothelium. Cell. Immunol. 203, 39–46 (2000).
Allport, J. R., Muller, W. A. & Luscinskas, F. W. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J. Cell Biol. 148, 203–216 (2000).
Cinamon, G., Shinder, V. & Alon, R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nature Immunol. 2, 515–522 (2001).
Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745 (1973).
Mishell, B. B. & Shiigi, S. M. Selected methods in cellular immunology (W. H. Freeman, San Francisco, 1980).
Acknowledgements
We thank K. Najid for technical assistance. Supported by NIH grants R01 HL64774 and HL46849 (to W. A. M.) and F32 HL10311 (to A. R. S.) and the Charles H. Revson Foundation (Z. M.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schenkel, A., Mamdouh, Z., Chen, X. et al. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 3, 143–150 (2002). https://doi.org/10.1038/ni749
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni749
This article is cited by
-
An Intriguing Structural Modification in Neutrophil Migration Across Blood Vessels to Inflammatory Sites: Progress in the Core Mechanisms
Cell Biochemistry and Biophysics (2024)
-
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation
Nature Immunology (2022)
-
TNF-α-Inhibition Improves the Biocompatibility of Porous Polyethylene Implants In Vivo
Tissue Engineering and Regenerative Medicine (2021)
-
Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma
Cancer Immunology, Immunotherapy (2021)
-
Immune cells lacking Y chromosome show dysregulation of autosomal gene expression
Cellular and Molecular Life Sciences (2021)